ICOS gets manufacturing contract from Lilly

Related tags Erectile dysfunction

ICOS has entered into a biologics manufacturing agreement with Eli
Lilly, in which the Bothell, Washington-based firm will manufacture
two clinical candidates

ICOS has entered into a biologics manufacturing agreement with Eli Lilly, in which the Bothell, Washington-based firm will manufacture two clinical candidates. The two companies have a history of close collaboration, most notably on the development of Cialis (tadalafil), a phosphodiesterase 5 inhibitor recently launched for erectile dysfunction. The identity of the two biological drugs was not disclosed.

August Watanabe, Lilly's soon-to-retire executive vice president for science and technology, said that the company had decided to outsource a portion of its biologics production and ICOS met its requirements for timely delivery.

ICOS clinical manufacturing facility​ is located in Bothell, Washington, and houses areas designed for current Good Manufacturing Practice-compliant production and purification of both cell culture and microbial fermentation products and can accommodate microbial fermentation of up to 1,600 litres and cell culture production up to 3,000 litres.

Related news

Related products

show more

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

Indena | 25-Oct-2022 | Technical / White Paper

Indena is well known in the space of naturally derived molecules, with a know-how developed over its one hundred year history. At the same time, the company...

Related suppliers

Follow us

Products

View more

Webinars